Search…

New stock news | Chuan Bo Wang Pharmaceutical is considering listing in Hong Kong and plans to raise about 300 million US dollars.

19/08/2025

According to the 36kr Finance APP, it is reported that Bojiang Pharmaceuticals is considering listing in Hong Kong, with plans to raise approximately $300 million. It is expected to become the largest biopharmaceutical IPO project in Hong Kong since 2024, apart from Hutchison Pharmaceuticals.

Latest

3 m ago

Abnormal movement in US stocks | Boeing (BA.US) falls more than 2% Airbus A320 deliveries are set to surpass Boeing's

4 m ago

Morgan Stanley analyst Joseph Moore predicts that Nvidia's revenue in July and October will exceed previous estimates, and accordingly raised the revenue/earnings per share outlook for 2026.

4 m ago

Morgan Stanley analyst Joseph Moore predicts that NVIDIA's revenue in July and October will surpass previous estimates and has accordingly raised the revenue/earnings outlook for 2026.

4 m ago

Morgan Stanley analyst Joseph Moore predicts that Nvidia will maintain about 85% of the AI data center chip market share in 2026, leaving competitors facing a daunting task of catching up.

4 m ago

Morgan Stanley analyst Joseph Moore predicts that Nvidia will maintain approximately 85% of the AI data center chip market share in 2026, making it a daunting task for competitors to catch up.

See all latest